AR003985A1 - Forma cristalina switterionica de trovafloxacina, procedimiento para su preparacion y composiciones que las contienen. - Google Patents
Forma cristalina switterionica de trovafloxacina, procedimiento para su preparacion y composiciones que las contienen.Info
- Publication number
- AR003985A1 AR003985A1 ARP960104121A AR10412196A AR003985A1 AR 003985 A1 AR003985 A1 AR 003985A1 AR P960104121 A ARP960104121 A AR P960104121A AR 10412196 A AR10412196 A AR 10412196A AR 003985 A1 AR003985 A1 AR 003985A1
- Authority
- AR
- Argentina
- Prior art keywords
- trovafloxacin
- preparation
- switterionica
- compositions
- procedure
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- WVPSKSLAZQPAKQ-CDMJZVDBSA-N trovafloxacin Chemical compound C([C@H]1[C@@H]([C@H]1C1)N)N1C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=NC=1N2C1=CC=C(F)C=C1F WVPSKSLAZQPAKQ-CDMJZVDBSA-N 0.000 title abstract 3
- 229960000497 trovafloxacin Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 150000004686 pentahydrates Chemical class 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Processing Of Solid Wastes (AREA)
- Physical Water Treatments (AREA)
Abstract
Una forma zwitteriónica de trovafloxacina de fórmula (I) seleccionada de entre el grupo formado por sus polimorfos higróscopicos y no higroscópicos ypentahidratos cristalinos y los procedimientos para su preparación. Dichos polímorfos comprenden un primer polimorfo PI no higroscópico, un segundopolimorfo PII higroscópico, y un pentahidrato del zwitterión de trovafloxacina tal como se describen en la memoria. La invención se refiere además aprocedimientos de uso, y composiciones farmacéuticas que los comprenden. Los compuestos de la invención se utilizan para el tratamiento de infeccionesbacterianas en mamíferos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US297595P | 1995-08-29 | 1995-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR003985A1 true AR003985A1 (es) | 1998-09-30 |
Family
ID=21703460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960104121A AR003985A1 (es) | 1995-08-29 | 1996-08-26 | Forma cristalina switterionica de trovafloxacina, procedimiento para su preparacion y composiciones que las contienen. |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0850060A1 (es) |
| JP (1) | JP3188476B2 (es) |
| KR (1) | KR100343909B1 (es) |
| CN (1) | CN1190889A (es) |
| AP (1) | AP636A (es) |
| AR (1) | AR003985A1 (es) |
| AU (1) | AU704115B2 (es) |
| BR (1) | BR9609998A (es) |
| CA (1) | CA2229786C (es) |
| CO (1) | CO4480739A1 (es) |
| CZ (1) | CZ56698A3 (es) |
| DZ (1) | DZ2087A1 (es) |
| GT (1) | GT199600072A (es) |
| HR (1) | HRP960395B1 (es) |
| HU (1) | HUP9900170A3 (es) |
| IL (1) | IL122651A (es) |
| MA (1) | MA23966A1 (es) |
| MY (1) | MY113874A (es) |
| NO (1) | NO309814B1 (es) |
| NZ (1) | NZ312199A (es) |
| OA (1) | OA10669A (es) |
| PE (1) | PE12598A1 (es) |
| PL (1) | PL325170A1 (es) |
| RU (1) | RU2144921C1 (es) |
| SK (1) | SK23898A3 (es) |
| TN (1) | TNSN96109A1 (es) |
| TR (1) | TR199800339T1 (es) |
| WO (1) | WO1997007800A1 (es) |
| YU (1) | YU48396A (es) |
| ZA (1) | ZA967282B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1998000106A (es) | 1997-08-01 | 1999-01-08 | Pfizer Prod Inc | Composiciones parenterales de alatroflaxacino |
| US7019142B2 (en) | 1998-01-16 | 2006-03-28 | Pfizer Inc. | Process for preparing naphthyridones and intermediates |
| PA8466701A1 (es) | 1998-01-21 | 2000-09-29 | Pfizer Prod Inc | Comprimido de mesilato de trovafloxacino |
| US6114531A (en) * | 1998-07-28 | 2000-09-05 | Pfizer Inc. | Process for preparing quinolone and naphthyridone carboxylic acids |
| HN1999000141A (es) * | 1998-09-03 | 2000-06-19 | Pfizer Prod Inc | Procedimiento para preparar sales de trovafloxacina de adicion de acidos. |
| US6239141B1 (en) | 1999-06-04 | 2001-05-29 | Pfizer Inc. | Trovafloxacin oral suspensions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS274601B2 (en) * | 1983-07-27 | 1991-09-15 | Dainippon Pharmaceutical Co | Method of 1,8-naphthyridine derivative production |
| AU623474B2 (en) * | 1989-01-16 | 1992-05-14 | Laboratoire Roger Bellon | New benzo(1,8)naphthyridine derivatives, their preparation and compositions containing them |
| US5164402A (en) * | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
| US5939550A (en) | 1995-06-15 | 1999-08-17 | Pfizer Inc. | Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
-
1996
- 1996-07-29 EP EP96923020A patent/EP0850060A1/en not_active Withdrawn
- 1996-07-29 SK SK238-98A patent/SK23898A3/sk unknown
- 1996-07-29 KR KR10-1998-0701468A patent/KR100343909B1/ko not_active Expired - Fee Related
- 1996-07-29 JP JP50343697A patent/JP3188476B2/ja not_active Expired - Fee Related
- 1996-07-29 IL IL12265196A patent/IL122651A/xx not_active IP Right Cessation
- 1996-07-29 CN CN96195624A patent/CN1190889A/zh active Pending
- 1996-07-29 CZ CZ98566A patent/CZ56698A3/cs unknown
- 1996-07-29 AU AU63676/96A patent/AU704115B2/en not_active Ceased
- 1996-07-29 NZ NZ312199A patent/NZ312199A/xx unknown
- 1996-07-29 HU HU9900170A patent/HUP9900170A3/hu unknown
- 1996-07-29 BR BR9609998A patent/BR9609998A/pt unknown
- 1996-07-29 RU RU98103873/04A patent/RU2144921C1/ru not_active IP Right Cessation
- 1996-07-29 TR TR1998/00339T patent/TR199800339T1/xx unknown
- 1996-07-29 WO PCT/IB1996/000756 patent/WO1997007800A1/en not_active Ceased
- 1996-07-29 PL PL96325170A patent/PL325170A1/xx unknown
- 1996-07-29 CA CA002229786A patent/CA2229786C/en not_active Expired - Fee Related
- 1996-08-23 GT GT199600072A patent/GT199600072A/es unknown
- 1996-08-26 AR ARP960104121A patent/AR003985A1/es unknown
- 1996-08-26 PE PE1996000633A patent/PE12598A1/es not_active Application Discontinuation
- 1996-08-28 DZ DZ960131A patent/DZ2087A1/fr active
- 1996-08-28 MY MYPI96003579A patent/MY113874A/en unknown
- 1996-08-28 YU YU48396A patent/YU48396A/sh unknown
- 1996-08-28 MA MA24344A patent/MA23966A1/fr unknown
- 1996-08-28 ZA ZA9607282A patent/ZA967282B/xx unknown
- 1996-08-28 TN TNTNSN96109A patent/TNSN96109A1/fr unknown
- 1996-08-29 AP APAP/P/1996/000853A patent/AP636A/en active
- 1996-08-29 CO CO96046149A patent/CO4480739A1/es unknown
- 1996-08-29 HR HR960395A patent/HRP960395B1/xx not_active IP Right Cessation
-
1998
- 1998-02-27 OA OA9800026A patent/OA10669A/en unknown
- 1998-02-27 NO NO980862A patent/NO309814B1/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28510A1 (es) | Compuestos quimicos | |
| CO4970821A1 (es) | Nuevos macrolidos | |
| AR126914A1 (es) | Inhibidores de ras novedosos | |
| GT198304062A (es) | Derivado epimerico de azahomoeritromicina a e intermedios del mismo | |
| AR034897A1 (es) | Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos | |
| ECSP099451A (es) | Compuestos de urea policíclicos antibacterianos | |
| ES2076147T3 (es) | Nuevos derivados de amina ciclicos, medicamento que contiene estos compuestos y procedimiento para su preparacion. | |
| BRPI0513717A (pt) | derivados de piridina | |
| AR007828A1 (es) | Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos | |
| UY25780A1 (es) | Nuevos antibióticos macrólidos | |
| MX9503529A (es) | Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen. | |
| CO4810375A1 (es) | Derivados de 9-amino-3-ceto eritromicina | |
| SV2004001555A (es) | Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos | |
| AR019496A1 (es) | Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos | |
| MX9306311A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| MX2022000598A (es) | Preparacion de compuestos antibacterianos. | |
| EA200600605A1 (ru) | Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств | |
| UY27410A1 (es) | Formas novedosas crudas cristalinas | |
| DK1448562T3 (da) | Substituerede tetracycliske pyrroloquinolonderivater egnede som phosphodiesteraseinhibitorer | |
| AR128066A1 (es) | Compuesto heterocíclico de pirimidina y método de preparación y uso médico de los mismos | |
| ECSP034598A (es) | Compuesto lactamico | |
| AR003985A1 (es) | Forma cristalina switterionica de trovafloxacina, procedimiento para su preparacion y composiciones que las contienen. | |
| ES2135351B1 (es) | Derivados de 5-aroilnaftaleno. | |
| CO2021018154A2 (es) | Compuestos y métodos de uso de los mismos como agentes antibacterianos | |
| UY27324A1 (es) | Nuevas sales de napsilato i |